Literature DB >> 30544357

Surgical outcomes after reoperation for recurrent non-skull base meningiomas.

Stephen T Magill1, Cecilia L Dalle Ore1, Michael A Diaz1, Daara D Jalili1, David R Raleigh1,2, Manish K Aghi1, Philip V Theodosopoulos1, Michael W McDermott1.   

Abstract

OBJECTIVERecurrent meningiomas are primarily managed with radiation therapy or repeat resection. Surgical morbidity after reoperation for recurrent meningiomas is poorly understood. Thus, the objective of this study was to report surgical outcomes after reoperation for recurrent non-skull base meningiomas.METHODSA retrospective review of patients was performed. Inclusion criteria were patients with recurrent meningioma who had prior resection and supratentorial non-skull base location. Univariate and multivariate logistic regression and recursive partitioning analysis were used to identify risk factors for surgical complications.RESULTSThe authors identified 67 patients who underwent 111 reoperations for recurrent supratentorial non-skull base meningiomas. The median age was 53 years, 49% were female, and the median follow-up was 9.8 years. The most common presenting symptoms were headache, weakness, and seizure. The WHO grade after the last reoperation was grade I in 22% of cases, grade II in 51%, and grade III in 27%. The tumor grade increased at reoperation in 22% of cases. Tumors were located on the convexity (52%), parasagittal (33%), falx (31%), and multifocal (19%) locations. Tumors involved the middle third of the sagittal plane in 52% of cases. In the 111 reoperations, 48 complications occurred in 32 patients (48%). There were 26 (54%) complications requiring surgical intervention. There was no perioperative mortality. Complications included neurological deficits (14% total, 8% permanent), wound dehiscence/infection (14%), and CSF leak/pseudomeningocele/hydrocephalus (9%). Tumors that involved the middle third of the sagittal plane (OR 6.97, 95% CI 1.5-32.0, p = 0.006) and presentation with cognitive changes (OR 20.7, 95% CI 2.3-182.7, p = 0.001) were significantly associated with complication occurrence on multivariate analysis. The median survival after the first reoperation was 11.5 years, and the 2-, 5-, and 10-year Kaplan-Meier survival rates were 91.0%, 68.8%, and 50.0%, respectively.CONCLUSIONSReoperation for recurrent supratentorial non-skull base meningioma is associated with a high rate of complications. Patients with cognitive changes and tumors that overlap the middle third of the sagittal plane are at increased risk of complications. Nevertheless, excellent long-term survival can be achieved without perioperative mortality.

Entities:  

Keywords:  GTR = gross-total resection; STR = subtotal resection; complications; convexity; falcine; falx; meningioma; morbidity; parasagittal; recurrent; skull base; supratentorial

Year:  2018        PMID: 30544357     DOI: 10.3171/2018.6.JNS18118

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

Review 1.  The Role of Surgery in Meningiomas.

Authors:  Michele Bailo; Filippo Gagliardi; Nicola Boari; Antonella Castellano; Alfio Spina; Pietro Mortini
Journal:  Curr Treat Options Neurol       Date:  2019-09-27       Impact factor: 3.598

Review 2.  Multimodality Therapy of Patients with Refractory Meningiomas.

Authors:  Haroon Ahmad; David Schiff
Journal:  Curr Treat Options Oncol       Date:  2019-05-09

3.  Small Cerebellopontine Angle Meningioma-Surgical Experience of 162 Patients and Literature Review.

Authors:  Jiyuan Bu; Pengjie Pan; Hui Yao; Weiyi Gong; Yuan Liu; Zhengquan Yu; Zhong Wang; Jiang Wu; Gang Chen
Journal:  Front Oncol       Date:  2020-10-09       Impact factor: 6.244

4.  Microscope-Based Augmented Reality with Intraoperative Computed Tomography-Based Navigation for Resection of Skull Base Meningiomas in Consecutive Series of 39 Patients.

Authors:  Mirza Pojskić; Miriam H A Bopp; Benjamin Saβ; Barbara Carl; Christopher Nimsky
Journal:  Cancers (Basel)       Date:  2022-05-06       Impact factor: 6.575

5.  Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.

Authors:  Michael A Mooney; Wenya Linda Bi; Jonathan M Cantalino; Kyle C Wu; Thomas C Harris; Lucas L Possatti; Parikshit Juvekar; Liangge Hsu; Ian F Dunn; Ossama Al-Mefty; Phillip M Devlin
Journal:  J Neurooncol       Date:  2019-11-19       Impact factor: 4.130

6.  Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature.

Authors:  Ramin A Morshed; Jacob S Young; Andrew J Gogos; Alexander F Haddad; James T McMahon; Annette M Molinaro; Vivek Sudhakar; Nadeem Al-Adli; Shawn L Hervey-Jumper; Mitchel S Berger
Journal:  Acta Neurochir (Wien)       Date:  2021-12-30       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.